| Original language | English |
|---|---|
| Pages (from-to) | 1588-1591 |
| Number of pages | 4 |
| Journal | Allergy: European Journal of Allergy and Clinical Immunology |
| Volume | 76 |
| Issue number | 5 |
| Early online date | 8 Oct 2020 |
| DOIs | |
| Publication status | Published - May 2021 |
Bibliographical note
Funding Information:PD reports grants from Stallergène Greer, grants from ALK, grants from AstraZeneca, grants from Bausch & Lomb, grants from Thermo Fisher Scientific, personal fees from Sanofi‐Regeneron. JMO reports personal fees from ASTRA ZENECA, personal fees from MUNDI‐PHARMA, personal fees from ALK. PSG reports personal fees from Allergopharma, personal fees from ALK, personal fees from AbbVie, grants from Christine Kühne Center for Allergy Research and Education CK‐CARE, personal fees from EliLilly, personal fees from GSK, from LEO, personal fees from Novartis, personal fees from Galderma, personal fees from Biomed, personal fees from Stallergenes, personal fees from Thermo Fisher, personal fees from Sanofi, outside the submitted work; and Peter Schmid‐Grendelmeier is outside of EAACI also member of the following societies: International society for atopic dermatitis ISAD (Board member)World Allergy Organization WAO Swiss Society for Allergy and Immunology SSAI (Board member) Swiss Society for Dermatology and Venerology SSDV European Academy for Dermatology and Venerology EADV European Dermatology Forum EDF. The other authors do not declare any conflict of interest.
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver